Receptor Tyrosine Kinases in Cancer

Receptor tyrosine kinases (RTKs) play a critical role in a variety of cellular processes including growth, differentiation, motility, and metabolism. RTKs are frequently overexpressed and their aberrant signalling is associated with various diseases including cancer. Thus, RTKs have become one of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor Corporativo: SpringerLink (Online service)
Outros Autores: Sabarwal, Akash (Editor), Tabasum, Saba (Editor), Pal, Soumitro (Editor)
Formato: Recurso Eletrônico livro eletrônico
Idioma:inglês
Publicado em: Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
Edição:1st ed. 2025.
coleção:Cancer Drug Discovery and Development,
Assuntos:
Acesso em linha:https://doi.org/10.1007/978-3-031-93894-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-93894-8
003 DE-He213
005 20260810165633.0
007 cr nn 008mamaa
008 250726s2025 sz | o |||| 0|eng d
020 |a 9783031938948  |9 978-3-031-93894-8 
024 7 |a 10.1007/978-3-031-93894-8  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Receptor Tyrosine Kinases in Cancer  |h [electronic resource] /  |c edited by Akash Sabarwal, Saba Tabasum, Soumitro Pal. 
250 |a 1st ed. 2025. 
264 1 |a Cham :  |b Springer Nature Switzerland :  |b Imprint: Springer,  |c 2025. 
300 |a 1 online resource (XXII, 365 p. 37 illus.). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b PDF/UA-1  |2 onix 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Drug Discovery and Development,  |x 2196-9914 
505 0 |a An Introduction to Receptor Tyrosine Kinases Signal Transduction and Cancer Progression -- Tyrosine Kinases and Inflammatory Signaling in Cancer -- Molecular Mechanisms of Acquired Therapeutic Resistance to Tyrosine Kinase Targeted Therapy -- AXL and its Role in Cell Migration and Epithelial to Mesenchymal Transition -- VEGFR and its Role in Tumor Angiogenesis -- c-MET Therapeutic Target and Biomarker in Cancer -- Receptor Tyrosine Kinase signaling and Mitochondria -- Therapeutic Potential of Targeting Immune Checkpoints Along with RTKs -- Combination therapies involving RTK inhibitors -- RTKs as a Therapeutic Target by Natural Compounds in Cancer Treatment. 
520 |a Receptor tyrosine kinases (RTKs) play a critical role in a variety of cellular processes including growth, differentiation, motility, and metabolism. RTKs are frequently overexpressed and their aberrant signalling is associated with various diseases including cancer. Thus, RTKs have become one of the most important druggable targets for the treatment of cancer. The emergence of small kinase inhibitors in cancer treatment offers a strategic approach to the management of cancer that surpasses the efficacy of traditional drugs. Understanding RTK signaling mechanisms is of paramount importance, especially as the US FDA and other global regulatory agencies have approved several small-molecule tyrosine inhibitors. Moreover, pharmaceutical companies are actively developing new compounds for the treatment of various malignancies. This comprehensive book addresses a timely need by presenting the latest advances and cutting-edge insights into RTKs in cancer research. The chapters provide overviews and recent developments regarding the roles of key RTKs —such as, c-Met, AXL, VEGFR, EGFR, among others—in pro-tumorigenic signaling, therapeutic resistance, and targeted inhibition across different cancer types. This volume serves as an essential resource for researchers and students seeking to deepen their understanding of this rapidly evolving field. . 
532 8 |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Cancer. 
650 0 |a Molecular biology. 
650 0 |a Biophysics. 
650 0 |a Cell interaction. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Molecular Biology. 
650 2 4 |a Mechanobiological Cell Signaling. 
700 1 |a Sabarwal, Akash.  |e editor.  |0 (orcid)0000-0003-1760-4903  |1 https://orcid.org/0000-0003-1760-4903  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Tabasum, Saba.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Pal, Soumitro.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031938931 
776 0 8 |i Printed edition:  |z 9783031938955 
776 0 8 |i Printed edition:  |z 9783031938962 
830 0 |a Cancer Drug Discovery and Development,  |x 2196-9914 
856 4 0 |u https://doi.org/10.1007/978-3-031-93894-8 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
912 |a ZDB-2-237 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708) 
950 |a Focus Bundle Biomedical and Human Health Sciences (SpringerNature-85407)